No black box warning on record for Adcetris

As of the latest FDA labeling reviewed, Adcetris (BRENTUXIMAB VEDOTIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Adcetris medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Peripheral neuropathy : Monitor patients for neuropathy and institute dose modifications accordingly ( 5.1 ). • Anaphylaxis and infusion reactions : If an infusion reaction occurs, interrupt the infusion. If anaphylaxis occurs, immediately discontinue the infusion ( 5.2 ). • Hematologic toxicities : Monitor complete blood counts. Monitor for signs of infection. Manage

No black box warning on record for Adcetris

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Peripheral neuropathy : Monitor patients for neuropathy and institute dose modifications accordingly ( 5.1 ). • Anaphylaxis and infusion reactions : If an infusion reaction occurs, interrupt the infusion. If anaphylaxis occurs, immediately discontinue the infusion ( 5.2 ). • Hematologic toxicities : Monitor complete blood counts. Monitor for signs of infection. Manage

Adcetris Black Box Warning

No black box warning on record for Adcetris

Other warnings & precautions

Adcetris Black Box Warning

No black box warning on record for Adcetris

Other warnings & precautions